Sector Gamma AS’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Sector Gamma AS’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-130,625	Closed	-$3.12M	–	40
2019 Q4	$3.12M	Buy	130,625 +4,700	+4%	+$130K	0.5%	33
2019 Q3	$3.38M	Sell	125,925 -78,000	-38%	-$2.19M	0.57%	31
2019 Q2	$5.53M	Sell	203,925 -50,576	-20%	-$1.59M	0.89%	30
2019 Q1	$8.83M	Sell	254,501 -30,200	-11%	-$871K	1.42%	22
2018 Q4	$5.56M	Buy	284,701 +15,000	+6%	+$308K	0.93%	28
2018 Q3	$7.18M	Buy	269,701 +68,901	+34%	+$2.25M	1.13%	23
2018 Q2	$7.58M	Buy	200,800 +66,000	+49%	+$2.52M	1.26%	23
2018 Q1	$4.4M	Buy	134,800 +84,800	+170%	+$3.72M	0.79%	26
2017 Q4	$2.43M	Buy	+50,000	New	+$2.53M	0.41%	33

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Sector Gamma AS's PTLA Position: Q1 2020 in Review

Sector Gamma AS sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 130,625 shares — an estimated $3.12M sold.

Sector Gamma AS first reported a position in PTLA in Q4 2017 and held it in 9 quarters. The position peaked at $8.83M in Q1 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

Sector Gamma AS reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Sector Gamma AS sold 130,625 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $3.12M.
Sector Gamma AS first reported a position in Portola Pharmaceuticals, Inc. in Q4 2017 and held it in 9 quarters.
Sector Gamma AS's Portola Pharmaceuticals, Inc. position peaked at $8.83M in Q1 2019.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Sector Gamma AS's 13F filing for Q1 2020, filed 11 May 2020.